segregated tumor-specific TILs from bystander lymphocytes (23), other authors found that the expression of CD137 or of PD-1 and the co-expression of CD39 and CD103 in intraepithelial TILs is associated with a high degree of anti-tumor reactivity (19, 24–26). The gene discussed is ENTPD1; the disease is neoplasm.